574 related articles for article (PubMed ID: 10952915)
1. Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations.
Lyng FM; Jones GR; Rommerts FF
Biol Reprod; 2000 Sep; 63(3):736-47. PubMed ID: 10952915
[TBL] [Abstract][Full Text] [Related]
2. Androgens rapidly increase the cytosolic calcium concentration in Sertoli cells.
Gorczynska E; Handelsman DJ
Endocrinology; 1995 May; 136(5):2052-9. PubMed ID: 7720654
[TBL] [Abstract][Full Text] [Related]
3. Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cells.
Sun YH; Gao X; Tang YJ; Xu CL; Wang LH
J Androl; 2006; 27(5):671-8. PubMed ID: 16728719
[TBL] [Abstract][Full Text] [Related]
4. Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP.
Swinnen JV; Esquenet M; Heyns W; Rombauts W; Verhoeven G
Mol Cell Endocrinol; 1994 Sep; 104(2):153-62. PubMed ID: 7527352
[TBL] [Abstract][Full Text] [Related]
5. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line.
Guillemette C; Hum DW; Bélanger A
Endocrinology; 1996 Jul; 137(7):2872-9. PubMed ID: 8770908
[TBL] [Abstract][Full Text] [Related]
6. The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells.
Lucia MS; Sporn MB; Roberts AB; Stewart LV; Danielpour D
J Cell Physiol; 1998 May; 175(2):184-92. PubMed ID: 9525477
[TBL] [Abstract][Full Text] [Related]
7. Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.
Berns EM; de Boer W; Mulder E
Prostate; 1986; 9(3):247-59. PubMed ID: 2946029
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of the biphasic action of androgens and of the potent antiproliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells.
de Launoit Y; Veilleux R; Dufour M; Simard J; Labrie F
Cancer Res; 1991 Oct; 51(19):5165-70. PubMed ID: 1913642
[TBL] [Abstract][Full Text] [Related]
9. Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors.
Berrevoets CA; Veldscholte J; Mulder E
J Steroid Biochem Mol Biol; 1993 Dec; 46(6):731-6. PubMed ID: 8274406
[TBL] [Abstract][Full Text] [Related]
10. Control of androgen cytosol receptor concentrations in Sertoli cells: effect of androgens.
Sanborn BM; Wagle JR; Steinberger A
Endocrinology; 1984 Jun; 114(6):2388-93. PubMed ID: 6202501
[TBL] [Abstract][Full Text] [Related]
11. A novel androgen signalling pathway uses dihydrotestosterone, but not testosterone, to activate the EGF receptor signalling cascade in prostate stromal cells.
Oliver VL; Poulios K; Ventura S; Haynes JM
Br J Pharmacol; 2013 Oct; 170(3):592-601. PubMed ID: 23869618
[TBL] [Abstract][Full Text] [Related]
12. Finasteride dose-dependently reduces the proliferation rate of the LnCap human prostatic cancer cell line in vitro.
Bologna M; Muzi P; Biordi L; Festuccia C; Vicentini C
Urology; 1995 Feb; 45(2):282-90. PubMed ID: 7855976
[TBL] [Abstract][Full Text] [Related]
13. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
[TBL] [Abstract][Full Text] [Related]
14. The synthetic androgen mibolerone induces transient suppression of the transformed phenotype in an androgen responsive human prostatic carcinoma cell line.
Schulz P; Wolf D; Arbusow V; Bojar H; Klobeck HG; Fittler F
Andrologia; 1990; 22 Suppl 1():56-66. PubMed ID: 2151880
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of growth and induction of apoptosis by androgens of a variant of LNCaP cell line.
Joly-Pharaboz MO; Ruffion A; Roch A; Michel-Calemard L; André J; Chantepie J; Nicolas B; Panaye G
J Steroid Biochem Mol Biol; 2000; 73(5):237-49. PubMed ID: 11070352
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the response of rat testis and accessory sex organs to treatment with testosterone and the synthetic androgen methyltrienolone (R1881).
van Roijen JH; Ooms MP; Weber RF; Brinkmann AO; Grootegoed JA; Vreeburg JT
J Androl; 1997; 18(1):51-61. PubMed ID: 9089068
[TBL] [Abstract][Full Text] [Related]
17. The proliferative effect of "anti-androgens" on the androgen-sensitive human prostate tumor cell line LNCaP.
Olea N; Sakabe K; Soto AM; Sonnenschein C
Endocrinology; 1990 Mar; 126(3):1457-63. PubMed ID: 2307113
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyflutamide affects connexin 43 via the activation of PI3K/Akt-dependent pathway but has no effect on the crosstalk between PI3K/Akt and ERK1/2 pathways at the Raf-1 kinase level in primary rat Sertoli cells.
Chojnacka K; Zarzycka M; Hejmej A; Mruk DD; Gorowska E; Kotula-Balak M; Klimek M; Bilinska B
Toxicol In Vitro; 2016 Mar; 31():146-57. PubMed ID: 26437446
[TBL] [Abstract][Full Text] [Related]
19. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells.
Ripple MO; Henry WF; Rago RP; Wilding G
J Natl Cancer Inst; 1997 Jan; 89(1):40-8. PubMed ID: 8978405
[TBL] [Abstract][Full Text] [Related]
20. Follicle-stimulating hormone and androgens increase the concentration of the androgen receptor in Sertoli cells.
Verhoeven G; Cailleau J
Endocrinology; 1988 Apr; 122(4):1541-50. PubMed ID: 2831032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
